EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genotypic analysis of drug-resistant tuberculosis in Ghana: Insights into pre-XDR and XDR-TB

Stephen Ofori Yirenkyi iD, Osmanu Taufik, Roger Laryea, Amanquador Acquah-Keelson, Japheth Awuletey Opintan iD, Gloria Ivy Mensah iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0323527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Stephen Ofori Yirenkyi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Department, Eastern Regional Hospital, Koforidua, Eastern Region, Ghana. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The emergence of Extensively Drug Resistant (XDR) and Pre-extensively drug resistant (Pre-XDR) tuberculosis (TB) threatens the management of multidrug-resistant tuberculosis (MDR) patients and impacts negatively on TB control programs, especially in developing countries like Ghana. The first case of XDR-TB in Ghana was reported in 2018. There is however inadequate data on the burden of XDR-TB and pre-XDR-TB and their associated resistant mutations in Ghana. The study sought to provide baseline data on the burden of pre-XDR-TB and XDR-TB among MDR TB cases in Ghana. It also determined the mutations responsible for pre-XDR/ XDR-TB, for clinical and programmatic management of pre-XDR/ XDR-TB in Ghana.

Methods

One hundred and seventy-one (171) archived clinical MDR isolates obtained from TB patients across Ghana between January 2016 and December 2020 were retrieved. The isolates were retested to confirm their phenotypic and genotypic susceptibility to the first and second-line anti-TB drugs using the BACTEC MGIT system and Genotype MTBDR plus , MTBDR sl , line probe assays respectively.

Results

Most of the 171 isolates came from 7 regions; the highest (39.5%) from Eastern, followed by Greater Accra region (19.8%). Most of the isolates were from male TB patients (78.9%). Of the 171 archived isolates, 81 (47.4%) were confirmed to be MDR, 6 (7.4%) were Pre-XDR-TB but no XDR-TB was detected. The katG S315T1 (33, 73.3%) and rpoB S531L (31, 42.5%) were the predominant mutations observed among isoniazid and rifampicin resistant isolates respectively. Many of the mutations and amino acid changes that caused pre-XDR-TB were gyrAWT3 + gyrAMUT3A and gyrAMUT3A (D94A) (50%) for fluoroquinolone. The other detected mutations with their amino acid changes were gyrA MUT1 (A90V), gyrA WT3 + gyrA MUT3C (D94G) and gyrA MUT2 (S91P) (16.7%) for fluoroquinolones and rrWT2 (position 1484) (33.3%) and rrs MUT2 (G1484T) (16.7%) for aminoglycosides.

Conclusion

The predominant mutations associated with pre-XDR-TB were D94A and C1402T for fluoroquinolone and aminoglycosides resistance respectively. The proportion of pre-XDR-TB among MDR-TB patients in Ghana was 7.4%; however, no XDR-TB was detected. A sustained surveillance of pre-XDR-TB and XDR-TB is recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisExtensively Drug-Resistant TuberculosisTuberculosis, Multidrug-ResistantHumansGhanaAntitubercular AgentsMaleFemaleAdultGenotypeMutationMicrobial Sensitivity TestsMiddle AgedYoung AdultAdolescentDrug Resistance, Multiple, Bacterial

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Laboratory Department, Eastern Regional Hospital, Koforidua, Eastern Region, Ghana.
  • Department of Medical Microbiology, University of Ghana Medical School, University of Ghana, Accra, Ghana.
  • Department of Medical Laboratory Sciences, School of Allied Health Sciences, University of Health and Allied Sciences, Ho, Ghana.
  • Department of Bacteriology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.

ORCID-Profile: Stephen Ofori Yirenkyi, Japheth Awuletey Opintan, Gloria Ivy Mensah

Zitieren

APA

Yirenkyi, S. O., Taufik, O., Laryea, R., Acquah-Keelson, A., Opintan, J. A., & Mensah, G. I. (2025). Genotypic analysis of drug-resistant tuberculosis in Ghana: Insights into pre-XDR and XDR-TB. PLOS One. https://doi.org/10.1371/journal.pone.0323527

Vancouver

Yirenkyi SO, Taufik O, Laryea R, Acquah-Keelson A, Opintan JA, Mensah GI. Genotypic analysis of drug-resistant tuberculosis in Ghana: Insights into pre-XDR and XDR-TB. PLOS One. 2025. doi:10.1371/journal.pone.0323527

BibTeX
@article{Yirenkyi2025,
  author = {Yirenkyi, Stephen Ofori and Taufik, Osmanu and Laryea, Roger and Acquah-Keelson, Amanquador and Opintan, Japheth Awuletey and Mensah, Gloria Ivy},
  title = {Genotypic analysis of drug-resistant tuberculosis in Ghana: Insights into pre-XDR and XDR-TB},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0323527}
}
Kostenlos starten →